An estimated 2.4 million people in the United States are living with hepatitis C virus (HCV)
infection. In 2020, the Centers for Disease Control and Prevention updated hepatitis C …

The science for rapid treatment initiation for hepatitis C virus infection is in place. Easy and
quick diagnostic tools can provide results within an hour. Necessary assessment before …

Abstract Background Hepatitis C virus (HCV) elimination requires treating people who use
drugs (PWUD), yet< 10% of PWUD in the United States access HCV treatment; access is …

New US Centers for Disease Control and Prevention (CDC) guidelines for hepatitis C virus
(HCV) testing of perinatally exposed infants and children released in 2023 recommend a …

The article by Varley et al published in this issue of Clinical Infectious Diseases is a
landmark study that highlights the effectiveness of a national hepatitis C virus (HCV) …

All‐oral, direct‐acting antivirals can cure hepatitis C virus (HCV) in almost all infected
individuals; yet, many individuals with chronic HCV are not treated, and the incidence of …

Introduction Despite universal access to government-funded direct-acting antivirals (DAAs)
in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most …

This study aimed to explore the current evidence on preventing blood-borne virus infections
among people who inject drugs (PWID). We conducted a comprehensive search across …

C 型肝炎(以下簡稱C 肝) 是由C 肝病毒透過血液或無保護性行為傳播感染所引起. 國內約有40
萬人是慢性C 肝患者, 盛行率約為4%, 遠高於全球平均的1%[1]. 近來, 由於C …

Many barriers prevent individuals with substance use disorders from receiving hepatitis C
virus (HCV) treatment. This study describes 96 patients with active HCV treated in an opioid …